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Proper brain neuronal circuitry formation and synapse development is dependent
on specific cues, either genetic or epigenetic, provided by the surrounding neural
environment. Within these signals, thyroid hormones (T3 and T4) play crucial role in
several steps of brain morphogenesis including proliferation of progenitor cells, neuronal
differentiation, maturation, migration, and synapse formation. The lack of thyroid hormones
during childhood is associatedwith several impair neuronal connections, cognitive deficits,
and mental disorders. Many of the thyroid hormones effects are mediated by astrocytes,
although the mechanisms underlying these events are still unknown. In this work,
we investigated the effect of 3, 5, 3’-triiodothyronine-treated (T3-treated) astrocytes on
cerebral cortex neuronal differentiation. Culture of neural progenitors from embryonic
cerebral cortex mice onto T3-treated astrocyte monolayers yielded an increment in
neuronal population, followed by enhancement of neuronal maturation, arborization and
neurite outgrowth. In addition, real time PCR assays revealed an increase in the levels
of the heparan sulfate proteoglycans, Glypican 1 (GPC-1) and Syndecans 3 e 4 (SDC-3
e SDC-4), followed by a decrease in the levels of the chondroitin sulfate proteoglycan,
Versican. Disruption of glycosaminoglycan chains by chondroitinase AC or heparanase III
completely abolished the effects of T3-treated astrocytes on neuronal morphogenesis.
Our work provides evidence that astrocytes are key mediators of T3 actions on cerebral
cortex neuronal development and identified potential molecules and pathways involved in
neurite extension; which might eventually contribute to a better understanding of axonal
regeneration, synapse formation, and neuronal circuitry recover.
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INTRODUCTION
Central nervous system (CNS) development is characterized by
differentiation of neural progenitors into different cell types,
proper neuronalmigration andmaturation, and axonal growth in
order to innervate specific targets. Accuracy in neuronal circuitry
formation and synapse development is dependent on specific cues
provided by the surrounding neural environment, either genetic
or epigenetic (Powell et al., 1997). Astrocytes, the most abun-
dant glial cell in the CNS, are source of most the extracellular
Abbreviations: ACM, astrocyte conditioned medium; C-CM, control astrocyte
conditioned medium; CM, conditioned medium; CNS, central nervous system;
CSPG, chondroitin sulfate-conjugated proteoglycan; D2, type II iodothyronine 5′-
deiodinase; DAPI, 4′,6-diamidino-2-phenylindole dihydrochloride; DMEM/F-12,
Dulbecco’s modified Eagle’s medium supplemented with nutrient mixture F-12;
E14, embryonic day fourteen; ECM, extracellular matrix; EGF, epidermal growth
factor; FBS, fetal bovine serum; FGF, fibroblast growth factor; GPC-1, Glypican 1;
HSPG, heparin sulfate conjugated-proteoglycan; PBS, phosphate-buffered saline;
SDC-3, Syndecans 3; SDC-4, Syndecan 4; T3, 3, 5, 3′-triiodothyronine; T3-CM, T3-
primed astrocyte conditioned medium; T4, Thyroxin; TBS-T, Tris-buffered saline-
Tween 20; TRs, thyroid hormones receptors; TRα, isoform α of TR; TRβ, isoform
β of TR.
matrix components (ECM) and neurotrophic factors involved in
these events, including 3, 5, 3′-triiodothyronine (T3), the bio-
logical active form of thyroid hormones, which are essential
morphogens of the nervous system (Garcia-Abreu et al., 1995;
Trentin et al., 1995; Ullian et al., 2001, 2004;Martinez andGomes,
2002; Christopherson et al., 2005; Lie et al., 2005; Martinez and
Gomes, 2005; Kornyei et al., 2007; Spohr et al., 2008; Barker and
Ullian, 2010; Stipursky et al., 2011, 2012; Tc et al., 2011).
Thyroid hormones, thyroxin (T4) and T3, influence critical
events in brain morphogenesis including neuronal migration and
differentiation, glial cells maturation, synaptogenesis, and myeli-
nation (Alvarez-Dolado et al., 1999; Auso et al., 2004; Cuevas
et al., 2005; De Escobar et al., 2007; Dezonne et al., 2009; Portella
et al., 2010). Hypothyroidism leads to impaired cerebral corti-
cal layering and altered callosal connections (Gravel et al., 1990;
Berbel et al., 1993; Calikoglu et al., 1996). Moreover, it has
been associated with clear reductions on axonal and dendritic
outgrowth (Eayrs, 1955; Ruiz-Marcos et al., 1979) as well as dis-
organization of dendritic spines and fewer synaptic connections
(Ruiz-Marcos et al., 1988) in experimental models. In humans,
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insufficient levels of thyroid hormones during brain development
are associated with severe neurological deficits that might result
in the cretinism syndrome (Joffe and Sokolov, 1994).
T4 is the predominant hormone form found in the nervous
tissue, where it is converted to the active form, T3, by the type
II iodothyronine 5′-deiodinase (D2), mainly expressed by astro-
cytes and tanycytes (Guadano-Ferraz et al., 1997; Santisteban and
Bernal, 2005). Activation of major signaling pathways by T3/T4
involves binding of T3 to nuclear receptors, although extranuclear
pathways have also been described (Santisteban and Bernal, 2005;
Bernal, 2007). Thyroid hormones nuclear pathway is triggered by
activation of thyroid hormone receptors alpha (TRα) and beta
(TRβ) widely expressed by neuronal and glial cells (Puymirat,
1992; Carlson et al., 1996; O’Shea and Williams, 2002; Bernal,
2007).
Despite thyroid hormones effects on neurons are well known,
several works have shown that some of these effects might be indi-
rectly controlled by astrocytes (Trentin and Moura Neto, 1995;
Gomes et al., 1999; Martinez and Gomes, 2002, 2005).
Thyroid hormones have been reported to modulate astrocyte
morphology, differentiation, and proliferation (Lima et al., 1997;
Trentin et al., 1998; Trentin, 2006), and to regulate ECM orga-
nization and synthesis (Farwell and Dubord-Tomasetti, 1999a,b;
Calloni et al., 2001; Martinez and Gomes, 2002; Mendes-De-
Aguiar et al., 2008). In vivo, thyroid hormones regulate radial
glia-astrocyte transition and the vimentin- glial fibrillary acidic
protein (GFAP) switch, a hallmark of astrocyte differentiation,
in the basal forebrain and hippocampus (Gould et al., 1990;
Martinez-Galan et al., 1997, 2004). Although astrocytes are evi-
dent targets for thyroid hormones in vitro and in vivo, the precise
effects of these hormones in neuron-astrocyte interactions are still
under investigation.
We previously demonstrated that thyroid hormone-treated
cerebellar astrocytes induce cerebellar progenitor proliferation
(Gomes et al., 1999) and neurite outgrowth (Martinez and
Gomes, 2002, 2005). These events result from the synthesis and
secretion of soluble factors, such as epidermal growth factor
(EGF), and the ECM molecules laminin (LN), fibronectin (FN)
and syndecans, producing a substrate for neuronal maturation
(Mendes-De-Aguiar et al., 2008, 2010).
In the present work, we investigated the role of cortical astro-
cytes as mediators of thyroid hormone T3, on neuronal matu-
ration, using an in vitro system consisting of astrocyte-neuron
cocultures. Here we report that thyroid hormone-primed astro-
cytes increase neuronal differentiation and neuritic arborization,
mainly by modulation of chondroitin and heparan sulfate proteo-
glycans (HSPG).
MATERIALS AND METHODS
ETHICAL APPROVAL
All animal protocols were approved by the Animal Research
Committee of the Federal University of Rio de Janeiro
(DAHEICB024).
ASTROCYTE PRIMARY CULTURE
Astrocytes primary cultures were prepared from cerebral cortex
derived from newborn Swiss mice, as previously described (Spohr
et al., 2008). Briefly, after mice decapitation, brain structures were
removed and the meninges were carefully stripped off. Tissues
were washed in phosphate-buffered saline (PBS), 0.6% glucose
(Merck, Darmstadt, Hessen, DE) and cortical structures were dis-
sociated into single cells in a medium consisting of Dulbecco’s
modified Eagle’s medium supplemented with nutrient mix-
ture F-12 (DMEM/F-12, Invitrogen Life Technologies, Carlsbad,
California, USA), enriched with glucose (3.3 × 10−2 M), glu-
tamine (2 × 10−3 M) and sodium bicarbonate (0.3 × 10−2 M).
Dissociated cells were plated onto plastic culture flask or glass
cover slips (24 wells plates, Techno Plastic Products, Trasadingen,
CH) previously coated with polyornithine (1.5μg/mL, molecu-
lar weight 41,000; Sigma Chemical Co., St Louis, Missouri, USA)
in DMEM/F12 supplemented with 10% fetal bovine serum (FBS)
(Invitrogen). The cultures were incubated at 37◦C in a humid-
ified 5% CO2, 95% air chamber. After 24 h, cell cultures were
washed and media were replaced by DMEM/F-12 supplemented
with 10% FBS. The medium was changed every second day until
reaching confluence.
T3 TREATMENT AND CONDITIONED MEDIUM (CM) PREPARATION
After reaching confluence, glial monolayers were washed three
times with serum-free DMEM/F12medium, and incubated for an
additional day in serum-free medium. After this period, cultures
were treated with 50 nM of T3 (Sigma Aldrich) in DMEM/F12 for
3 days with daily medium change. Control astrocyte carpets were
maintained in DMEM/F12 without serum. After that, glial mono-
layers were washed three times with serum-free DMEM/F12 and
maintained for an additional day with serum-free medium. CMs
derived from T3-treated (T3-CM) or control cultures (C-CM)
were recovered, centrifuged at 1500 g for 10min, and used imme-
diately or stored at −70◦C for further use.
ENZYMATIC TREATMENT OF ASTROCYTE MONOLAYERS
To analyze a possible influence of glycosaminoglycans, astro-
cyte monolayers were enzymatically digested with chondroiti-
nase AC (5.0 × 10−7 U/μL) (that specifically digests chon-
droitin sulfate glycosaminoglycan chains) or heparanase III
(5.0 × 10−7 U/μL) [that specifically digests heparan sulfate gly-
cosaminoglycan (HSG) chains] (Sigma Aldrich) in DMEM/F12,
for 2 h at 37◦C, prior to addition of progenitor cells. After, cul-
tures were extensively washed with medium without serum to
remove all residual enzymes, followed by addition of neuronal
progenitors to astrocyte monolayers.
NEURAL PROGENITOR CULTURE AND ASTROCYTE-NEURAL
PROGENITOR COCULTURE
Pregnant Swiss females with 14-gestational days were killed by
halothane followed by cervical dislocation, and embryos (E14)
were removed. Cortical progenitors were prepared as previously
described (Spohr et al., 2008). Briefly, for coculture assays cells
were freshly dissociated from cerebral cortex and 5 × 104 cells
were plated onto control, thyroid hormones-treated glial mono-
layer carpets or onto astrocyte-carpets previously digested with
chondroitinase or heparanase III. Cocultures were kept for 24 h
at 37◦C in a humidified 5% CO2, 95% air atmosphere. For pure
neural progenitor cultures 1 × 105 dissociated cells were plated
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onto glass cover slips previously coated with polyornithine, and
incubated with C-CM or T3-CM. Cultures were kept for 24 h at
37◦C in a humidified 5% CO2, 95% O2 air atmosphere.
IMMUNOCYTOCHEMISTRY
Cells were fixed with 4% paraformaldehyde for 5min for ECM
protein analyses or 15min, for cytoskeleton protein analyses.
For cytoskeleton proteins analysis, cells were additionally per-
meabilized with 0.2% Triton-X (Vetec Química Fina Ltda, Rio
de Janeiro, Rio de Janeiro, BR) for 5min at room temperature.
Subsequently, cells were blocked with 5% bovine serum albu-
min (Invitrogen) and 3% normal goat serum (Invitrogen) in PBS
(block solution) for 1 h and incubated overnight at 4◦C with the
specified primary antibody diluted in block solution. Primary
antibodies were mouse anti−βTubulin III antibody (Promega
Corporation; Madison, Wisconsin, USA; 1:1000); rabbit anti-
GFAP (Dako, Glostrup, DK; 1:500); rabbit anti-Fibronectin
(Sigma Aldrich; 1:200); rabbit anti-Laminin (Sigma Aldrich;
1:100). After primary antibodies incubation, cells were extensively
washed in PBS and incubated with the following secondary anti-
bodies diluted in block solution for 2 h: goat anti-mouse IgG con-
jugated with Alexa Fluor 488 or goat anti-rabbit IgG and anti-rat
IgG conjugated with Alexa Fluor 546 (Molecular Probes, Eugene,
Oregon, USA; 1:400, 1:500, and 1:1000, respectively). Cell nuclei
were labeled with 4’,6-diamidino-2-phenylindole dihydrochloride
(DAPI) and cell preparations were mounted directly on N-propyl
gallate (Sigma Aldrich). Negative controls were obtained by omit-
ting primary antibodies; in all cases, no reactivity was observed.
After immunostaining, cell cultures were visualized and counted
using a TE300 Nikon microscope. At least 10 fields were counted
per well.
NEURONAL MORPHOMETRY
To analyze neurite outgrowth, neuronal cells cultured either onto
astrocyte monolayers or onto glass cover slips, were measured
using the NeuronJ plug-in of Image J 1.36 b software. At least 10
fields were measured per well. In all cases, at least 100 neurons
randomly chosen were observed per well. All neurites emerged
from neuronal soma were considered. Neurite length was ana-
lyzed by 3 different methods either considering only the major
process per neurons, the sum of all neurite measurements per
neuron and the sum of all neurite measurements divided by the
number of process per neuron.
WESTERN BLOT
Protein concentration on cell extracts wasmeasured by the BCA™
Protein Assay Kit (Pierce, IL, USA). Fifty micrograms of pro-
tein per lane were eletrophoretically separated in 5–15% gradient
sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE). After
separation, proteins were electrically transferred onto a Hybond-
P polyvinylidene difluoride transfer membrane (Amersham
Biosciences, Little Chalfont, Buckinghamshire, UK) for 3 h.
Membranes were blocked overnight in Tris-buffered saline-Tween
20 (Merck) (TBS-T) containing 10% BSA. Primary antibodies
were added for 2 h at room temperature. After several washes in
TBS-T, peroxidase-conjugated secondary antibodies were added
to membrane and incubated for 2 h at room temperature.
Proteins were visualized using the enhancing chemiluminescence
detection system (Super Signal West Pico Chemiluminescent
Substrate/Pierce, Milwaukee, Wisconsin, USA), and PVDF mem-
branes were exposed to autoradiographic films (Kodak, São José
dos Campos, São Paulo, BR). Primary antibodies were mouse
anti−α-Tubulin (Sigma Aldrich; 1:5000); rabbit anti-Fibronectin
(Sigma Aldrich; 1:1000); rabbit anti-Laminin (Sigma Aldrich;
1:1000). Secondary peroxidase-conjugated antibodies were goat
anti-rabbit IgG and goat anti-mouse IgG (Amersham Biosciences;
1:5000). After protein detection, densitometric analysis of autora-
diographic films was done using Image J 1.36 b software.
RT-PCR
Total RNA was isolated from cells using TRIZOL (Invitrogen)
according to the protocol provided by the manufacturer. After
DNAse treatment (RQ1 RNAse-free DNAse, Promega Wisconsin,
USA), RNA samples (up to 1.5μg) were reverse-transcribed into
cDNA using oligo (dT) and Super ScriptTM II Reverse transcrip-
tase (Invitrogen). cDNAwas amplified by TaqDNAPolymerase in
103 PCR Buffer using Invitrogen’s protocol. Sense and antisense
specific oligonucleotides were in Table 1. Amplification was per-
formed in 35 cycles, and PCR products were size-fractionated by
electrophoresis using a 2% agarose gel and visualized by ethidium
bromide staining. Negative controls for genomic DNA contami-
nation were carried out. Densitometries were done using Image J
1.36 b software.
QUANTITATIVE RT-PCR
Total RNA was Trizol® (Invitrogen, USA) extracted from astro-
cytes monolayers were used for RNA extraction and RNA
was quantified using NanoDrop ND-1000 Spectrophotometer
(Thermo Fisher Scientific, USA). Two micrograms of total RNA
were reverse-transcribed with Oligo (dT) 15 Primer and ImProm-
II Reverse Transcription System with Recombinant RNasin®
Ribonuclease inhibitor (Promega, USA) and MgCl2. The primer
sequences were verified to be specific using GenBank’s BLAST
(Altschul et al., 1997). The primers used in this assay were in
Table 1. Quantitative real-time RT-PCR was performed using
SYBR®-Green PCR Master Mix, including AmpliTaq-GOLD
polymerase (Applied Biosystems, USA). Reactions were per-
formed on ABI PRISM 7500 Real Time PCR System (Applied
Biosystems). The relative expression levels of genes were calcu-
lated using the 2−CT method (Livak and Schmittgen, 2001).
The amount of target genes expressed in a sample was normalized
to the average of the endogenous control. This is given by CT,
where CT is determined by subtracting the average endogenous
gene CT value from the average target gene CT value [CT tar-
get gene—CT average (endogenous gene)]; where 2−CT is the
relative expression of the target gene compared to the endoge-
nous gene. The calculation of CT was done by subtracting
CT value for the controls from the CT value for a given treat-
ment [CT target gene (treated)—CT target gene (control)];
where 2−CT is the relative expression of the target gene at
T3-treated astrocytes compared to controls.
ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISA)
A quantitative indirect immunoenzyme assaywas performed after
the protein levels were measured. Polystyrene microtiter plate
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Table 1 | Specifications of the oligonucleotides used in conventional and real time RT-PCR.
Gene Sequence Product (bp)
GFAP 5′ CGA TTC AAC CTT TCT CTC CAA ATC CAC ACG 3′ 339
5′ CTT TGC TAG CTA CAT CGA GAA GGT CCG CTT 3′
TRα1 5′ GGT GCT GCA TGG AGA TCA TG 3′ 225
5′ GGA ATG TTG TGT TTG CGG TG 3′
TRβ1 5′ CGG AGG AGA AGA AAT GTA AAG G 3′ 421
5′ GCT TCG GTG ACA GTT TTG AT G 3′
Dio2 5′ CTT GAC TTT GCC AGT GCA GA 3′ 351
5′ GCA CAC ACG TTC AAA GGC TA 3′
GAPDH 5′ AAG AAG GTG GTG AAG CAG GCA TCT 3′ 200
5′ ACC CTG TTG CTG TAG CCG TAT TCA 3′
Syndecan-3 5′ TCG TTT CCT GAT GAT GAA CTA GAC 3′ 301
5′ GTG CTG GAC ATG GAT ACT TTG TT 3′
Syndecan-4 5′ AGA GCC CAA GGA ACT GGA AGA GAA 3′ 147
5′ ATC AGA GCT GCC AAG ACC TCA GTT 3′
Glypican-1 5′ ACT CCA TGG TGC TCA TCA CTG ACA 3 151
5′ TTT CCA CAG GCC TGG ATG ACC TTA 3′
Versican 5′ TCC AGG AGA AAC AGT TGG GAT GCT 3′ 192
5′ AAG GAA GGA AAG GTT GGC CTC TCA 3′
wells (Maxisorp, Nunc, and Roskilde, Denmark) were coated
with 50μL of protein (5μg/mL in PBS) by passive adsorption
overnight at 4◦C. The plates were then washed with PBS contain-
ing 0.05% Tween 20 and 0.1% BSA (PBS-Tween). Non-specific
binding was blocked by incubating the plates for 2 h with 1% BSA
in PBS, pH 7.4 at 37◦C. After an additional PBS-Tween wash-
ing, the plates were incubated with the primary antibodies, rabbit
anti-Fibronectin (Sigma Aldrich; 1:1000); rabbit anti-Laminin
(Sigma Aldrich; 1:1000) and mouse anti−α-Tubulin (as control)
(Sigma, USA; 1:3000) for 24 h at 4◦C, followed by incubation
with a goat anti-rabbit or mouse IgG peroxidase-linked conju-
gated antibody (1:8000 Amersham Biosciences, UK). The plates
were washed with PBS-Tween, and the reaction was developed
with the substrate o-phenylenediamine (0.5mg/mL and 0.005%
H2O2 in 0.01M sodium citrate buffer, pH 5.6) (Vetec, Brazil).
The reaction was stopped with 0.2M H2SO4 (Vetec, Brazil),
and the absorbance was measured using an automated reader
(BioRad ELISA Reader, Hercules, CA, USA). The experimental
groups consisted of triplicate samples from three independent
experiments.
STATISTICAL ANALYSES
Statistical analyses were done using one-way non-parametric
ANOVA coupled with Tukey post-test by GraphPad Prism
4.0 software, and P < 0.05 was considered statistically sig-
nificant. The experiments were performed in triplicate, and
each result represents the mean of at least four independent
experiments.
RESULTS
CEREBRAL CORTEX ASTROCYTES PRIMED BY T3 INDUCE NEURONAL
FATE COMMITMENT AND ENHANCE NEURONAL MATURATION
In order to evaluate the role of astrocytes as mediators of T3
in cerebral cortex neuron development, astrocyte monolayers
derived from newborn cerebral cortex were primed by 50 nM
of T3 for 3 days, followed by coculture with embryonic cerebral
cortex progenitors for 24 h (Figures 1A,B).
RT-PCR assays of control astrocyte monolayers demonstrated
that astrocytes express both TRα1 and TRβ1 receptors, as well
type II deiodinase (D2) mRNAs, thus, ensuring that they might
respond to thyroid hormone (Figure 1C).
Culture of progenitor cells onto T3-primed astrocyte mono-
layers yielded a 44% increase in neuronal population as
revealed by immunostaining for the neuronal marker βTubulinIII
(Figure 1D). Morphometric analysis revealed an 80% increase in
the number of neurons with three or more processes, followed
by a 62% decrease of aneuritic cells, when neurons were cultured
onto T3-primed astrocyte carpets (Figure 1E).
In order to evaluate the effect of thyroid hormones-treated
astrocytes on axonal growth, neurite length was analyzed by
three parameters: either considering the sum of total neurite
length per neuron; the longest neurite per neuron or the sum
of all neurite measurements divided by the number of pro-
cess per neuron. Treatment of astrocytes by T3 promoted a
75% increment on neurite outgrowth (Figure 1F). Moreover,
around 33% of neuronal cells plated over astrocyte monolay-
ers treated with thyroid hormones developed neurites with an
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average size around 100–150μm whereas less than 15% of neu-
rons plated over control astrocytes displayed these characteristics
(Figure 1G). Treatment of astrocytes by T3 greatly decreased the
number of neurons with neurites under 50μm (control: 23% ×
T3-treated: 1%) and increased those bigger than 150μm (control:
2% × T3-treated: 10–18%) (Figure 1G).
Together, these results show that thyroid hormone induce
astrocytes to adopt a permissive and/or inductive phenotype that
favors neuronal fate specification of cortical progenitors followed
by further neuronal maturation and arborization.
FIGURE 1 | Thyroid hormone-primed astrocytes induce neuronal
differentiation and arborization: Cortical progenitors obtained from E14
mice were cultured onto untreated (A; Control) and T3 (B) astrocyte
monolayers. After 24 h of coculture, neurons were morphologically
characterized by βtubulin III (βtubIII+) immunostaining for number of
neurons (D), number of neurites (E) and length of neurites (F,G). In all
cases, at least 100 neurons randomly chosen were observed. RT-PCR
assays identified expression of members of thyroid hormone signaling
pathway in cultured cortical astrocytes: TRα1, TRβ1, and D2 mRNAs (C).
Note the complexity of neuronal cells plated over T3-astrocytes (e”)
compared with control-astrocytes (e’). Increase in arborization complexity
was also followed by an increment in neurite length (G). Scale bars: 50μm
(A), 10μm (e’). ∗P < 0.05; ∗∗∗P < 0.001.
EFFECT OF ASTROCYTES SOLUBLE FACTORS ON NEURONAL
DIFFERENTIATION AND MATURATION
Astrocytes constitute the main source of neurotrophic factors
during nervous system development (Banker, 1980; Martinez
and Gomes, 2002; Kornyei et al., 2007). In order to investi-
gate if neuronal arborization induced by T3-primed astrocytes
was mediated by soluble factors, embryonic cerebral cortex pro-
genitors were cultured in the presence of conditioned medium
obtained from control astrocytes (C-CM) or T3-treated astrocytes
(T3-CM), for 24 h (Figures 2A,B) and number of neurons quan-
tified after immunostaining for the neuronal marker, βTubulin
III. T3-CM had no effect in the number of βTubulin III posi-
tive cells compared to C-CM (Figure 2C). On the other hand,
T3-CM enhanced neuronal arborization as revealed by a decrease
FIGURE 2 | Astrocytic soluble factors secreted in response to thyroid
hormones affect neuronal differentiation. E14 cerebral cortex progenitors
were cultured in the presence of control conditioned medium obtained
from non-treated astrocytes (A; C-CM) and T3-treated astrocytes (B;
T3-CM) for 24 hr. Neurons were morphologically characterized by βtubulin
III (βtubIII+) immunostaining for number of neurons (C), number of neurites
(D) and length of neurites (E,F). Note that although T3-CM enhanced
neuronal arborization and neurite outgrowth (d”), it did not affect number of
neurons (C). Scale bars: 50μm (A), 10μm (d’). ∗P < 0.05.
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FIGURE 3 | Thyroid hormones do not affect levels and organization of
laminin and fibronectin on cerebral cortex astrocytes. After reaching
confluence, cerebral cortex primary astrocyte cultures were maintained for 3
days in DMEM-F12 medium alone (Control) or supplemented with T3 (T3).
Cells were immunostained for Fibronectin (A,B) and Laminin (C,D). Thick
fibrils characteristics of ECM networks are shown throughout the
extracellular membrane surface. DAPI stained nuclei (blue) reveal astrocyte
monolayers localized underneath Fibronectin and Laminin matrix (green). No
significant differences in the organization and distribution of both ECM
proteins were observed (A–D). ELISA assays of total protein extracts from
cortical astrocyte cultures, did not reveal any difference in Fibronectin or
Laminin levels in control or T3-treated cultures (E). Western blot assays of
total protein extracts from cortical astrocyte cultures did not reveal
differences in the protein levels after T3 treatment of cortical astrocytes (F,G).
Immune reaction for α-Tubulin was used as loading control.
Scale bar: 30μm (A).
in the number of aneuritic cells (T3-CM: −23%), followed
by an increase in those cells with 2 neurites (T3-CM: +58%)
(Figure 2D). Likewise, neurite outgrowth was improved by con-
ditioned medium derived from T3-treated astrocytes (Figure 2E).
In the presence of T3-CM, most of the neurons presented neu-
rites with average size between 50 and 100μm, whereas most of
those in C-CM exhibited an average size between 10 and 50μm
(Figure 2F). Nevertheless, T3-CMwas not able to fully mimic the
effects of cocultures on neuronal differentiation and arborization
(compare Figures 1, 2), suggesting, a role for astrocyte-neuron
contact factor in this process.
THYROID HORMONES-TREATED ASTROCYTES INDUCE NEURONAL
DIFFERENTIATION AND NEURITE OUTGROWTH THROUGH
MODULATION OF PROTEOGLYCANS COMPONENTS
ECM proteins are key regulators of neuronal differentiation,
migration, axonal projection, neurite outgrowth, synaptoge-
nesis, and regeneration (Faivre-Bauman et al., 1984; Carri
et al., 1988; Hammarback et al., 1988; Chamak and Prochiantz,
1989; Martinez and Gomes, 2002). Recently, we demonstrated
that astrocytes cultured under hypothyroidism-like conditions,
present FN decreased level (Dezonne et al., 2009). Moreover,
we also described that thyroid hormone treatment induces FN
and LN reorganization in cerebellar astrocytes (Martinez and
Gomes, 2002). We then sought to investigate if thyroid hor-
mone treatment affects synthesis and organization of cerebral
cortex astrocytic ECM. To accomplish that, the content of LN
and FN of cortical astrocytes was evaluated by immunocytochem-
istry, western blot, and ELISA assays (Figure 3). In all conditions,
immunolabeling showed the thick and fibrous networks staining
pattern of these two proteins, with no clear difference between
control and treated-astrocytes (Figures 3A–D). Equally, neither
ELISA nor western blot assays revealed any obvious differences
in LN or FN protein levels (Figures 3E–G), suggesting that other
components of ECM might be involved in the neurite outgrowth
induced by T3-primed astrocytes.
A large number of proteoglycans have been implicated in
regulation of neurite outgrowth. These molecules provide sig-
nals that either stimulate or inhibit axonal growth during CNS
morphogenesis (Williamson et al., 1996). HSPG are generally
correlated with neuronal maturation and neurite outgrowth
(Bespalov et al., 2011; Mammadov et al., 2012). In order to inves-
tigate if thyroid hormone treatment affects the expression of
HSPGs in cerebral cortex astrocytes, we performed a quantita-
tive RT-PCR for the two family of HSPG: syndecan (SDC) and
glypican (GPC). T3-primed astrocytes presented an increase of
100%, in the expression of SDC4 and GPC1, and 98% of SDC3
(Figure 4A).
We then sought to analyze the involvement of the HSPG com-
ponents in cerebral cortex glia-induced neuronal fate commit-
ment and axonal growth. To do that, astrocyte monolayers were
treated with heparanase III, which specifically digests HSG chains,
after T3 treatment and previously to coculture assays. Enzymatic
digestion of HSG chains completely abolished the increase in
neuronal population induced by thyroid hormones treatment
(Figures 4B–F). It also reversed neurite outgrowth (Figure 4G),
but not the increase in neurite number (Figure 4H) induced by
T3-treated astrocytes.
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FIGURE 4 | Thyroid hormone-primed astrocytes induce neuronal
differentiation, arborization and neurite outgrowth through
heparan-sulfate proteoglycans. Cortical astrocytes cultures were
evaluated for Glypican 1 (GPC1) and Syndecans 3 and 4 (SDC3,
SDC4) heparan-sulfate proteoglycans mRNA expression by real time
RT-PCR. Representative graph analysis shows that T3 promoted
increase in GPC1, SDC3, and SDC4 expression (A). Cortical control
astrocytes (B,D) or treated with T3 (C,E) were enzymatically treated
with Heparanase III (D,E) previously to addition of embryonic cortical
progenitors. After 24 hr of coculture, number of neurons (F), length
of neurites (G) and number of neurites (H) were evaluated.
Digestion of heparan chains completely impaired the effects produced
by T3 in neuronal number, arborization and neurite outgrowth. Scale
bars: 50μm (B), ∗P < 0.05.
Growing axons navigate complex environments thus, integrat-
ing with local structural and chemical cues in order to make net
growth decisions. This process is driven by positive and negative
clues present in neuronal neighborhood. Among the inhibitoriest
molecules to axonal growth are chondroitin sulfate proteoglycans
(CSPG) (Nakamae et al., 2009). We thus analyzed the levels of
Versican, the major CSPG in the brain and which has been shown
to inhibit neurite outgrowth in vitro and in vivo following injury
(Morgenstern et al., 2002). Quantitative RT-PCR assays revealed a
50% decrease in the expression of Versican in T3-treated astrocyte
monolayers (Figure 5A).
To evaluate if CSPGmight be also responsible for the neuronal
maturation induced by T3-treated astrocytes, we enzymatically
treated astrocyte monolayers with chondroitinase AC, prior to
addition of E14 cerebral cortex progenitors. The digestion of
chondroitin sulfate glycosaminoglycan chains completely abol-
ished the increase in neuronal population induced by thyroid
hormones treatment (Figures 5B–F). Besides, chondroitinase AC
completely inhibited neurite outgrowth induced by T3-treated
astrocytes (Figure 5G). Unexpectedly, the absence of inhibitor
clues, enhance the extension of neurite by neurons (Figure 5H).
Taken together, these data show that T3 induces differentia-
tion and axonal growth of cerebral cortex neurons by modulation
of positive and negative signals: through enhancement of HSPG
levels and decreasing versican expression by astrocytes.
DISCUSSION
Here we report that T3-primed astrocytes induce neuronal matu-
ration and neurite outgrowth of embryonic neural progenitors.
These events are mediated by signals derived from HSPG and
CSPG, specifically GCP1, SDC3, SDC4, and versican. Our work
provides evidence of a novel mechanism, through astrocytes,
underlying thyroid hormone effects in cerebral cortex develop-
ment. The fact that astrocytes highly express several isoforms
of TRs makes them strong targets for thyroid hormones action
during nervous system development (Carlson et al., 1996; Morte
et al., 2004). Our findings support experimental observations that
correlate thyroid hormones insufficiencies with clear reductions
in axonal and dendritic growth (Eayrs, 1955; Ruiz-Marcos et al.,
1979, 1988), and they strengthen the role of astrocytes in these
processes, suggesting a thyroid hormone-indirect action on neu-
ronal cells.
Thyroid hormone-conditioned medium also increased astro-
cyte permissivity to neurite outgrowth, although in less scale than
coculture systems, leading to the hypothesis that either astro-
cyte conditioned medium (ACM) contains a soluble factor with
redundant effects of cell contact on these events; or the effects
of the ACM are due to soluble proteoglycans. The identity of
the putative astrocyte-derived soluble factor should await further
investigation.
Congenital hypothyroidism characterized by morphological
brain alterations results in disturbed neuronal migration, deficits
in axonal projection and synaptogenesis (Eayrs, 1955; Ruiz-
Marcos et al., 1979, 1988; Gravel et al., 1990; Berbel et al., 1993;
Calikoglu et al., 1996; Cuevas et al., 2005). It is well known that
signals derived from ECM are essential to these events, especially
those triggered by FN and LN (Carri et al., 1988; Hammarback
et al., 1988; Chamak and Prochiantz, 1989; Martinez and Gomes,
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FIGURE 5 | Thyroid hormone-primed astrocytes induce neuronal
differentiation, arborization, and neurite outgrowth through
chondroitin-sulfate proteoglycans. Cortical astrocytes cultures were
evaluated for Versican chondroitin-sulfate proteoglycan mRNA expression by
real time RT-PCR. Representative graph analysis shows that T3 promoted
decrease in the Versican expression (A). Cortical control astrocytes (B,D) or
treated with T3 (C,E) were enzymatically treated with chondroitinase AC
(D,E) previously to addition of embryonic cortical progenitors. After 24 hr,
number of neurons (B,F), length of neurites (G) and number of neurites (H)
were evaluated. Digestion of chondroitin chains completely impaired the
effects produced by T3-astrcoytes in neuronal number and neurite outgrowth.
Scale bars: 50μm (B), ∗P < 0.05; ∗∗∗P < 0.001.
2002). We previously demonstrated that thyroid hormones
induce neurite outgrowth of cerebellar granular neurons through
synthesis and secretion of FN and LN in vitro (Martinez and
Gomes, 2002). These data contrast with those shown here since
we did not observe any alteration in both ECM proteins, either
at their levels or organization in the extracellular matrix. These
apparent discrepancies might be due to species specificity, since
in previous work rats were used and here we used cerebral cor-
tex derived from mice. An alternative possibility is that these
differences reflect astrocyte heterogeneity within CNS, since
those works analyzed hormone effects in cerebellar development
instead of cerebral cortex. It is known that astroglial cells derived
from distinct brain regions markedly vary in their responsiveness
to thyroid hormone (Lima et al., 1997). It has also been speculated
that spatial differences in the expression of T3 receptors account
for the variety of T3 response elicited in brain structures (Lima
et al., 1997; Gomes et al., 1999).
Another possible explanation is that thyroid hormones exert
an indirect action on LN and FN mediated by secondary growth
factors secreted in response to hormone treatment. This is sup-
ported by the fact that a direct T3-regulation has not been
undoubtedly reported for LN and FN, whereas several growth fac-
tors secreted by astrocytes in response to thyroid hormone, like
EGF and FGF2, have been shown to modulate ECM components
(Calloni et al., 2001; Martinez and Gomes, 2002; Mendes-De-
Aguiar et al., 2010). Our data agree with those obtained from
Farwell and Dubord-Tomasetti who demonstrated that T4, but
not T3, increases LN expression (Farwell and Dubord-Tomasetti,
1999a,b).
Enzymatic digestion of glycosaminoglycan chains, with chon-
droitinases AC and heparanase III, completely abolished the
effects of thyroid hormone primed-astrocytes on neuronal phe-
notype acquisition observed here, although a basal neurite
extension was observed in all conditions. Since the optimum
concentration of HSPG to elicit neurite outgrowth in vitro is
unknown, one possibility is that the remaining HSPG, either
in control or T3-treated cultures, is sufficient to induce a basal
neurite extension. In fact, our data show that both heparan
sulfate and chondroitin sulfate glycosaminoglycan chains were
important for neurite outgrowth, since we only disrupted gly-
cosaminoglycan chains instead of core proteins. However, it
might be related with an alteration in HSPG and CSPG expres-
sion by T3-treated astrocytes. In mammalian tissues, most of
glycosaminoglycans are covalently linked to proteins, forming the
proteoglycans. These macromolecules exert important roles dur-
ing morphogenesis and homeostasis of the CNS (Carey, 1997;
Song and Filmus, 2002; Matsui and Oohira, 2004). Although
specific receptors have not been identified for these molecules,
they mainly act by interacting with cell adhesion molecules and
growth factors (Wang et al., 2008; Mythreye and Blobe, 2009).
The CNS presents multiple species of proteoglycans in the ECM
and at cell surface, including the two families of HSPG, synde-
cans and glypicans (Bandtlow and Zimmermann, 2000; Matsui
and Oohira, 2004), and many CSPGs, such as neurocan, versican
and aggrecan (Carey, 1997; Bandtlow and Zimmermann, 2000;
Oohira et al., 2000; Song and Filmus, 2002; Akita et al., 2004;
Matsui and Oohira, 2004).
The study of the role of proteoglycans in CNS development
and pathology has provided contradictory results regarding their
permissive or inhibitory effects on axonal growth. In the adult
CNS, CSPGs are upregulated after CNS injury and constitute
the main component of the glial scar, which impairs axonal
regeneration (Jones et al., 2003; Wang et al., 2008). The 4-
sulfated chondroitin chains have been shown to repeal growing
axons of several cell types including cerebellar granular cells
and dorsal root ganglion neurons (Oohira et al., 2000; Matsui
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and Oohira, 2004; Wang et al., 2008). However, Wang and co-
workers have also shown that in reactive astrocyte monolayers,
6-sulfated chondroitin did not show any inhibitory action on
axonal guidance. In addition, ascending sensory axons regener-
ate into areas where CSPG is expressed after spinal cord injury
(Pasterkamp et al., 2001; Inman and Steward, 2003). Versican
is an ECM CSPG, and its isoforms are aberrantly expressed
in CNS injuries. Diverse works suggest that versican plays key
inhibitory role in regulating neurite outgrowth (Zhang et al.,
2011). In the present work, we showed that T3-treated astrocytes
decreased versican expression, which might contribute to neurite
outgrowth.
HSPG are permissive to neurite outgrowth and among
them is the transmembrane family of HSPG, SDC. Here, we
demonstrated that enhanced expression of SDC 3 and 4 by
T3-treated astrocytes is associated with neuronal maturation.
These data are in concert with reduced expression of SDC
1, 2, and 4, and increased expression of SDC3 in hypothy-
roid cerebellum (Mendes-De-Aguiar et al., 2008). Furthermore,
a reduced expression of SDC2 and 3 in T3-treated astro-
cytes has been previously associated with T3 action mediated
by FGF2 in cerebellar astrocytes. In this case, proteoglycans
were suggested to affect the formation of the trimeric sig-
naling receptor complex composed by SDC/FGF/FGF-receptor,
which is essential for FGF receptor dimerization, activa-
tion, and cell signaling (Mendes-De-Aguiar et al., 2008).
It is known that SDC3 are involved in biological func-
tions such as cell adhesion, cell migration and neurite out-
growth (Akita et al., 2004; Choi et al., 2011). N-syndecan
(SDC3) is abundantly expressed in the major axonal path-
ways and in the migratory routes of the developing brain.
They might associate with heparin-binding growth-associated
molecule (pleiotrophin), and mediates cortactin-Src kinase-
dependent neurite outgrowth (Hienola et al., 2006). In addi-
tion, SDC3 might bind to neurocan, a major CSPG expressed
by neurons, thus, promoting neurite outgrowth (Akita et al.,
2004). Thus, it is not completely unpredicted that CSPG
might be permissive to certain neuronal types under pecu-
liar conditions. Besides, SDC family might have a chon-
droitin sulfate modification, thus, presenting a hybrid class
of proteoglycans (Bernfield et al., 1999). Yet, a balance
between inhibitor and permissive molecules, rather than indi-
vidual molecules, might be a determinant factor to neurite
outgrowth.
Glypicans are another important family of HSPG. GPCs are
linked to extracellular surface of plasmic membrane through
a covalent glycosyl-phosphatidylinositol (GPI) anchor. Six GPC
were described in mammals so far (GPC1-6). In general, they
are expressed predominantly during development when they
control tissues morphogenesis (Song and Filmus, 2002). GPC1,
the major HSPG of the brain, displays a higher expression
level throughout CNS, mainly in the developing neuroepithe-
lium surrounding ventricles (Litwack et al., 1998; Song and
Filmus, 2002). Previously works reported that two members
of the Slit family, Slit1 and 2, bind to GPC1, and have an
overlapping patter of expression in the brain (Ronca et al.,
2001). Slits proteins are expressed by neurons and glial cells
and play key role in axonal guidance (Brose and Tessier-Lavigne,
2000). In addition, we found an increment of amyloid pre-
cursor protein (APP) mRNA in T3-treated astrocytes (data not
shown). It is well known that SDC3 GPC1 also binds to APP
and this interaction promotes neurite outgrowth (Williamson
et al., 1996; Clarris et al., 1997; Cheng et al., 2011; Hoe
et al., 2012). In this case, neuronal SDC3 and GPC1 might
also require astrocyte APP for neurite outgrowth. Here, we
showed for the first time that the thyroid hormone, T3, induces
neurite outgrowth through upregulating GPC1 expression in
astrocyte.
We demonstrated that thyroid hormone induces neuronal
maturation and neurite outgrowth of cerebral cortex neu-
rons in vitro and implicated SDC3 and 4, GPC1 and ver-
sican produced by astrocytes, in these events. Moreover, we
shed light on glial cells as potential targets of thyroid hor-
mone actions during cerebral cortex neuronal development.
Upon hormone influence, astrocytes secrete soluble factors,
downregulate ECM proteins, specifically, versican CSPG; and
upregulate HSPG (SDC3-4, GPC1) thus affecting neuronal
pool: either inducing neuronal commitment of progenitor
cells and, further, neuronal maturation and neurite outgrowth
(Figure 6).
Our work not only increases the knowledge about thy-
roid hormone role in brain development but helps to identify
potential molecules and pathways involved in neurite extension
which might eventually contribute to a better understanding of
axonal regeneration, synapse formation, and neuronal circuitry
recover.
FIGURE 6 | Indirect effects of thyroid hormone on neuronal
differentiation through astrocytes. The thyroid hormone, T3, induces
astroglial cells (1) to modulate ECM molecules expression, such as heparan
sulfate and chondroitin sulfate glycosaminoglycans and soluble factors (2),
which in turn induce neuronal commitment of progenitor cells followed by
their differentiation (3), and maturation with neurite outgrowth (4a). In
parallel, postmitotic neurons can be direct targets of astrocyte-derived
molecules, thus, promoting maturation and neurite outgrowth (4b).
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